|
Atenolol EP Impurity E
|
阿替洛爾 EP 雜質(zhì)E
|
141650-31-9
|
|
Itraconazole Impurity G
|
伊曲康唑雜質(zhì)G
|
|
|
Itraconazole EP Impurity B
|
伊曲康唑EP雜質(zhì)B
|
854372-77-3
|
|
Atenolol EP Impurity D
|
阿替洛爾 EP 雜質(zhì)D
|
115538-83-5
|
|
Itraconazole EP Impurity D
|
伊曲康唑EP雜質(zhì)D
|
89848-49-7
|
|
Itraconazole EP Impurity E
|
伊曲康唑EP雜質(zhì)E
|
252964-65-1
|
|
Itraconazole EP Impurity F
|
伊曲康唑EP雜質(zhì)F
|
89848-51-1
|
|
Itraconazole N-Oxide
|
伊曲康唑N-氧化物
|
|
|
Atenolol Impurity 1
|
阿替洛爾雜質(zhì)1
|
81346-71-6
|
|
Atenolol EP Impurity I
|
阿替洛爾 EP 雜質(zhì)I
|
1797116-92-7
|
|
Atenolol
|
阿替洛爾
|
29122-68-7
|
|
Atenolol EP Impurity F
|
阿替洛爾 EP 雜質(zhì)F
|
87619-83-8
|
|
Gliclazide Impurity 5
|
格列齊特雜質(zhì)5
|
39051-77-9
|
|
Gliclazide Impurity 6
|
格列齊特雜質(zhì)6
|
1207714-41-7
|
|
Gliclazide
|
格列齊特
|
21187-98-4
|
|
Gliclazide Impurity 1
|
格列齊特雜質(zhì)1
|
38173-52-3
|
|
Gliclazide Impurity 2
|
格列齊特雜質(zhì)2
|
14437-03-7
|
|
Gliclazide Impurity 3 HCl
|
格列齊特雜質(zhì)3鹽酸鹽
|
58108-05-7
|
|
Gliclazide Impurity 4
|
格列齊特雜質(zhì)4
|
107628-27-3
|
|
Atenolol Impurity C
|
阿替洛爾雜質(zhì)C
|
29122-69-8
|
|
Orlistat USP Related Compound C
|
奧利司他USP相關(guān)化合物C
|
791-28-6
|
|
Orlistat USP Related Compound E
|
奧利司他USP相關(guān)化合物E
|
1072902-75-0
|
|
Atenolol Impurity D
|
阿替洛爾雜質(zhì)D
|
|
|
Atenolol Impurity F
|
阿替洛爾雜質(zhì)F
|
156-38-7
|
|
Atenolol EP Impurity H
|
阿替洛爾 EP 雜質(zhì)H
|
29277-73-4
|
|
Atenolol EP Impurity G Sodium Salt
|
阿替洛爾 EP 雜質(zhì) G 鈉鹽
|
56392-14-4
|
|
Gliclazide EP Impurity C
|
格列齊特EP雜質(zhì)C
|
5577-13-9
|
|
Gliclazide EP Impurity F
|
格列齊特EP雜質(zhì)F
|
1076198-18-9
|
|
Guaifenesin EP Impurity B
|
愈創(chuàng)甘油醚EP雜質(zhì)B
|
14007-09-1
|
|
Guaifenesin EP Impurity C
|
愈創(chuàng)甘油醚EP雜質(zhì)C
|
1797132-23-0
|
|
Guaifenesin EP Impurity D
|
愈創(chuàng)甘油醚EP雜質(zhì)D
|
16929-60-5
|
|
Guaifenesin
|
愈創(chuàng)甘油醚
|
93-14-1
|
|
Nicotinic Acid EP Impurity E;Isoniazid EP Impurity A
|
異煙肼EP雜質(zhì)A;煙酸 EP 雜質(zhì) E
|
55-22-1
|
|
Isoniazid EP Impurity B
|
異煙肼EP雜質(zhì)B
|
|
|
Isoniazid Impurity 1
|
異煙肼雜質(zhì)1
|
15420-02-7
|
|
Aciclovir ;Acyclovir EP Impurity K
|
阿昔洛韋EP雜質(zhì)K
|
1797131-64-6
|
|
Aciclovir ;Acyclovir EP Impurity J
|
阿昔洛韋EP雜質(zhì)J
|
166762-90-9
|
|
Acyclovir ;Aciclovir EP Impurity P
|
阿昔洛韋EP雜質(zhì)P
|
23169-33-7
|
|
Aciclovir ;Acyclovir EP Impurity M
|
阿昔洛韋EP雜質(zhì)M
|
91702-60-2
|
|
Lenalidomide
|
來那度胺
|
191732-72-6
|
|
Lenalidomide Impurity 7
|
來那度胺雜質(zhì)7
|
2197414-55-2
|
|
Lenalidomide Glucosides
|
來那度胺葡萄糖苷
|
|
|
Linagliptin Impurity 41
|
利格列汀雜質(zhì)41
|
1638744-06-5
|
|
Linagliptin Impurity 25
|
利格列汀雜質(zhì)25
|
1803079-49-3
|
|
Linagliptin Impurity 18
|
利格列汀雜質(zhì)18
|
1646355-34-1
|
|
Linagliptin Impurity 66
|
利格列汀雜質(zhì)66
|
668273-75-4
|
|
Linagliptin Impurity 73
|
利格列汀雜質(zhì)73
|
666816-98-4
|
|
Linagliptin Impurity 21
|
利格列汀雜質(zhì)21
|
666816-91-7
|
|
Linagliptin impurity 14
|
利格列汀雜質(zhì)14
|
1446263-38-2
|
|
Linagliptin Impurity 81
|
利格列汀雜質(zhì)81
|
668270-12-0
|
|
Rosuvastatin EP Impurity G Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) G 鈉鹽
|
1242184-42-4
|
|
Rosuvastatin Impurity 73
|
瑞舒伐他汀雜質(zhì)73
|
1797419-58-9
|
|
Orlistat USP Related Compound B
|
奧利司他USP相關(guān)化合物B
|
19740-72-8
|
|
Orlistat USP Related Compound A
|
奧利司他USP相關(guān)化合物A
|
104872-06-2
|
|
Gliclazide EP Impurity E
|
格列齊特EP雜質(zhì)E
|
|
|
Gliclazide EP Impurity G
|
格列齊特EP雜質(zhì)G
|
|
|
Gliclazide EP Impurity D
|
格列齊特EP雜質(zhì)D
|
1136426-19-1
|
|
Orlistat Related Compound D
|
奧利司他USP相關(guān)化合物D
|
130793-27-0
|
|
Orlistat
|
奧利司他
|
96829-58-2
|
|
Gliclazide EP Impurity B
|
格列齊特EP雜質(zhì)B
|
54786-86-6
|
|
Atenolol EP Impurity A
|
阿替洛爾 EP 雜質(zhì)A
|
17194-82-0
|
|
Atenolol EP Impurity B
|
阿替洛爾 EP 雜質(zhì)B
|
61698-76-8
|
|
Rosuvastatin EP Impurity L
|
瑞舒伐他汀EP雜質(zhì)L
|
|
|
Rosuvastatin EP Impurity C
|
瑞舒伐他汀EP雜質(zhì)C
|
1422619-13-3
|
|
Rosuvastatin EP Impurity C Sodium Salt
|
瑞舒伐他汀EP雜質(zhì)C鈉鹽
|
1620823-61-1
|
|
Rosuvastatin EP Impurity D
|
瑞舒伐他汀EP雜質(zhì)D
|
503610-43-3
|
|
Acyclovir ;Aciclovir EP Impurity F
|
阿昔洛韋EP雜質(zhì)F
|
110104-37-5
|
|
Acyclovir ;Aciclovir EP Impurity L
|
阿昔洛韋EP雜質(zhì)L
|
3056-33-5
|
|
Acyclovir ;Aciclovir EP Impurity C
|
阿昔洛韋EP雜質(zhì)C
|
91702-61-3
|
|
Acyclovir ;Aciclovir EP Impurity A
|
阿昔洛韋EP雜質(zhì)A
|
102728-64-3
|
|
Acyclovir ;Aciclovir EP Impurity G
|
阿昔洛韋EP雜質(zhì)G
|
75128-73-3
|
|
Acyclovir ;Aciclovir Impurity H
|
阿昔洛韋雜質(zhì)H
|
133186-23-9
|
|
Rosuvastatin EP Impurity K Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) K 鈉鹽
|
|
|
Rosuvastatin 4,6-Diene Impurity
|
瑞舒伐他汀4,6-二烯雜質(zhì)
|
1422954-13-9
|
|
3-O-Ethyl Rosuvastatin
|
3-O-乙基瑞舒伐他汀
|
|
|
Rosuvastatin EP Impurity M Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) M 鈉鹽
|
847849-66-5
|
|
Rosuvastatin EP Impurity I Calcium Salt
|
瑞舒伐他汀 EP 雜質(zhì) I 鈉鹽
|
|
|
Rosuvastatin Impurity H Sodium Salt
|
瑞舒伐他汀雜質(zhì) H 鈉鹽
|
1335110-44-5
|
|
Rosuvastatin EP Impurity F
|
瑞舒伐他汀EP雜質(zhì)F
|
289042-12-2
|
|
Rosuvastatin EP Impurity A Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) A 鈉鹽
|
1714147-50-8
|
|
Rosuvastatin EP Impurity J Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) J 鈉鹽
|
|
|
Rosuvastatin EP Impurity E Sodium Salt
|
瑞舒伐他汀 EP 雜質(zhì) E 鈉鹽
|
|
|
Rosuvastatin Calcium Salt
|
瑞舒伐他汀鈣鹽
|
147098-20-2
|
|
Mesalazine EP Impurity E
|
美沙拉嗪EP雜質(zhì)E
|
65-49-6
|
|
Mesalazine Impurity ZY2
|
美沙拉嗪雜質(zhì)ZY2
|
|
|
Metoclopramide EP Impurity F
|
甲氧氯普胺EP雜質(zhì)F
|
38339-95-6
|
|
Metoclopramide EP Impurity B (Metoclopramide USP Related Compound B)
|
甲氧氯普胺EP雜質(zhì)B
|
4093-31-6
|
|
N-Acetyl Metoclopramide HCl
|
N-乙酰甲氧氯普胺鹽酸鹽
|
|
|
Metoclopramide EP Impurity G HCl
|
甲氧氯普胺EP雜質(zhì)G鹽酸鹽
|
171367-22-9
|
|
Metoclopramide Impurity 8
|
甲氧氯普胺雜質(zhì)8
|
50-86-2
|
|
Dacomitinib Impurity ZY1
|
達(dá)克替尼雜質(zhì) ZY1
|
|
|
Apixaban
|
阿哌沙班
|
503612-47-3
|
|
Dacomitinib
|
達(dá)克替尼
|
1110813-31-4
|
|
Dacomitinib Impurity 1
|
達(dá)可替尼雜質(zhì)1
|
179552-75-1
|
|
Apixaban Related Compound 3
|
阿哌沙班相關(guān)化合物 3
|
813452-05-0
|
|
O-Desmethyl Apixaban
|
O-去甲基阿哌沙班
|
503612-76-8
|
|
Apixaban Related Compound 4
|
阿哌沙班相關(guān)化合物 4
|
99585-01-0
|
|
Apixaban Impurity 8
|
阿哌沙班雜質(zhì)8
|
1777781-49-3
|
|
Apixaban Impurity 7
|
阿哌沙班雜質(zhì)7
|
1074549-87-3
|
|
Apixaban Impurity 24
|
阿哌沙班雜質(zhì)24
|
1928718-22-2
|